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Nasty processes produce  
nasty guidelines
The guideline from the National Institute for 
Health and Clinical Excellence (NICE) on 
urinary tract infections (UTI) in childhood1 
was welcomed in a BMJ editorial.2 3 Most 
readers will assume it was based on evidence 
correctly analysed by medical statisticians, 
robustly peer reviewed, and openly debated. 
As this is a controversial subject, dependent 
more on small studies than randomised 
controlled trials, many will imagine that 
it represented consensus following wide 
consultation, as stated.1 Sadly, all these 
assumptions are wrong.
The NICE guideline committee signed 
highly restrictive secrecy agreements, and its 
two paediatric nephrologists did not consult 
with the British Association for Paediatric 
Nephrology, whose members hold diverse 
views. I was a peer reviewer but was 
not treated as one. My first draft review 
identified major flaws, was supported by the 
association, and delayed publication by six 
months. However, I was allowed to see the 
committee’s adjustments only after strong 
insistence, signing a secrecy document, and 
accepting that it would ignore my responses. 
The errors persist.
The guidelines were derived from an 
inadequate review of the literature. The 
authors misused statistics and reached 
beyond the evidence to make erroneous 
conclusions based on flawed logic. Some 
seemed to reflect opinion rather than fact. 
The committee’s own figures showed that 
nitrite screening has a mean sensitivity of 
about 50%, so will miss half the cases, yet 
it1 and Watson2 advise its use unreservedly. 
Similarly, both promote the use of 
ultrasound rather than dimercaptosuccinic 
acid (DMSA) scans, despite their own 
data showing DMSAs to be much more 
sensitive; on average ultrasound misses half 
the scars. They also view DMSA as invasive 
even though it requires only a single 
venepuncture and has the radiation burden 
of one abdominal x ray. Both advise a 
temperature cut off of 38°C for investigating 
infants’ urines without clear evidence, 
and both assume that a lack of evidence 
for prophylactic antibiotics equates to 
evidence against their benefit, which many 
paediatricians dispute.
NICE guidelines result in uniformity of 
practice; clinicians “are expected to follow 
them.”4 Unifying practice before a consensus 
emerges is absurd. Scientific debates are 
not resolved by secrecy and decree but 
by patient research and genuinely open 
discussion. The premature imposition of 
inappropriate guidelines will stifle new 
clinical developments. For example, our 
unit runs a direct access service,5 which 
seems to be reducing renal scarring rates 
(despite Watson’s assertion that most scars 
are congenital2). If we are all forced into one 
mould based on poor analysis of evidence, 
we will miss the opportunity to make 
important advances.
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Author’s reply
The guideline on urinary tract infection 
(UTI) in children from the National Institute 
for Health and Clinical Excellence (NICE) 
will precipitate debate, but hopefully cause 
less consternation than that expressed by 
Coulthard (previous letter). The published 
clinical guideline runs to 150 pages and 271 
references with many systematic reviews.1 
We can all quote observational studies 
that don’t pass the scrutiny of evidence 
based medicine, but perhaps we should 
remember that the 1991 Royal College of 
Physicians guidelines were produced by 18 
“experts” at a one day consensus meeting 
with medical audit in mind. 
Achieving a further consensus has been 
difficult, with imaging modalities changing 
from intravenous urogram and micturating 
cystogram for all to ultrasound, radionuclide 
imaging, and more selective cystograms. 
At the same time, recognition has been 
increasing that a lot of what we called reflux 
nephropathy is reflux associated damage in 
association with congenital dysplastic and 
obstructive kidneys.
The algorithms that were devised didn’t 
really distinguish between upper tract and 
lower tract infection. As most children 
only have a single episode and recover 
there has been legitimate concern about 
over-investigation. The NICE guideline 
helps us focus on important groups—young 
people and patients with unexplained fever, 
atypical UTI, or recurrent UTI. Prompt 
diagnosis and treatment are emphasised, 
but debate will continue about the relative 
merits of microscopy and dipsticks. One 
point to bear in mind is that UTI is a 
combination of symptoms and growth of 
organisms from an appropriately taken urine 
sample. Clinical decision making can be 
difficult,  but the NICE guidelines clearly 
state that “the guidance does not, however, 
override the individual responsibility of 
healthcare professionals to make decisions 
appropriate to the circumstances of the 
individual patient, in consultation with the 
patient and/or guardian or carer.” This may 
certainly be appropriate in the debated 
area of antibiotic prophylaxis. A recent 
Cochrane review quoted only two small 
studies where no significant differences in 
risk for UTI were found between antibiotic 
prophylaxis and no treatment.2 We urgently 
need a controlled trial in this area, especially 
as compliance with long term prophylaxis 
is probably worse than we think and some 
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raise the abysmal standards of practice in the 
UK and then examine incentives to improve 
results still further if needed.
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PoPUlatIoN growth
Colonialism never dies
Interesting to see that old colonial opinions 
still flourish at the BMJ. Having decided that 
African women are intelligent enough to 
hold down jobs but not to bottle feed safely, 
thereby putting countless babies at risk, they 
are now to be told to limit their families.1
Africans like having large families. 
No doubt that will change in time, but 
that should be determined by the people 
themselves, not by Europeans, who like 
having long haul holidays and driving large 
cars and are not prepared to give them 
up. The options suggested for limiting 
population growth include contraception, 
which presents problems with choice of 
method and access and “safe abortion.” If 
that takes off in Africa with the enthusiasm 
that it has in this country the annual health 
budget will be mopped up.
How about doing what the Africans want? 
In my experience, although the death of a 
child is mourned, it is, in time, accepted. 
Funds should be diverted from keeping 
children alive to ensuring optimum health 
for their parents by establishing some form 
of health facility in every area, supplying 
medical assistants with bicycles, ensuring 
a safe supply of front line drugs, and 
discussing, intelligently, the problem of safe 
childbirth—and maybe improve the roads 
so that women can get to hospital or teach 
village practitioners to do caesarean sections.
How about tackling the problem of the 
tsetse fly that devastates large areas of Africa, 
which not only causes trypanosomiasis 
(said to be increasing), but also means no 
draught animals and no dairy products? If 
parents and carers express concern about 
long term usage. However, children are 
our priority and we must justify to them the 
taking of the nasty medicine and the need 
for potentially nasty invasive tests.
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ImProvINg stroke oUtCome
Apply science, not politics
Markus leaps from a discussion about 
outcomes to a plea to reorganise 
acute stroke care to improve access to 
thrombolysis.1 Not one patient received 
thrombolytic treatment in the studies he 
quotes, but such subtleties will be lost in the 
political hubbub about the NHS letting us 
all down yet again. It is frustrating that after 
25 years’ research, we have only one drug 
treatment, alteplase, which seems to work, 
and we only manage to give it to 2% of our 
patients, but we should not put all our eggs 
in this basket.
About 1 in 8 patients would expect to 
obtain major benefit from thrombolytic 
treatment, so even if we could increase 
the proportion treated to 20%, about 1 
in 40 patients would benefit overall. To 
achieve this, Markus suggests that patients 
receive “rapid ambulance assessment” 
and perhaps half would be transferred 
to “specialised stroke centres,” some 
distance away.1 What of the patients not 
transferred and condemned to “second class 
care” in their local hospital? This would 
presumably include anyone over 80 (over 
30% of patients with acute stroke) as there is 
insufficient evidence of benefit for alteplase 
to be licensed in this age group. What of 
the many patients rushed to the specialist 
hospital in the hope of getting clot busting 
treatment but found to be unsuitable? The 
logistics are nightmarish, and the sense 
of frustration among those whose hopes 
are dashed would be fertile soil for media 
mischief. Inevitably, the risks and limitations 
of alteplase would be ignored, and it would 
become yet another wonder drug being 
denied to thousands of NHS patients.
The only proved effective treatment 
for most patients with stroke is specialist, 
multidisciplinary team based, stroke unit 
care.2 Good coordination, communication, 
and continuity of care are essential 
ingredients, and these would be put at risk 
if large numbers of patients received acute 
care and rehabilitation in different trusts, 
looked after by different teams. There is 
no reason why patients with acute stroke, 
admitted to any reasonably sized hospital, 
should not have access to immediate 
brain scanning and expert assessment, if 
necessary via telemedicine links, but we 
need to develop these services quickly and 
quietly, without hyperbole and fuss.
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drUg mIsUsers aNd INCeNtIves
Methadone works if  
used properly
Stevenson, a senior British forensic doctor, 
observes that methadone treatment does not 
work, contrary to 40 years of high quality 
research showing that it does.1
The reason can be found in the lack 
of adherence to evidence based clinical 
guidelines in much of the United Kingdom.2 
With some notable exceptions, UK addicts 
are routinely given dose schedules that are 
contrary to guidelines (such as mean doses 
of less than 40 mg daily in place of double 
that found in well run clinics). These advise 
strict dose supervision for new and unstable 
patients with an effective dose range from 60 
mg to 120 mg daily after careful induction 
starting with no more than 40 mg daily.3
Hong Kong, Australia, and New Zealand 
may be the only places where methadone 
has been available for over 30 years under 
reasonably open access and with a largely 
evidence based approach. Uniquely, all 
three have very little HIV in their large 
injecting populations. Few would believe 
this is coincidental (although hepatitis C 
has been a different and as yet unanswered 
story).
The question of whether addicts should 
receive incentives in treatment should be 
decided by practical research, not moralist 
opinions.4 5 Methadone treatment is already 
one of the most cost effective things we do 
in medicine and probably compares with 
washing hands. It would seem logical to 
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public trust in doctors undented
The BMA does not take public trust 
in doctors for granted nor does it 
underestimate the potential for adverse 
reactions from the public or patients to 
events such as Bristol and Alder Hey.1 
Accordingly, it has commissioned regular 
research via MORI on the issue and did 
so at intervals during the 1980s and 1990s 
and on an annual basis between 1999 and 
2005. The findings support a conclusion 
of ongoing trust and belief in medical 
competence, with little deviation even at 
times of highly adverse publicity.
The public was asked whether it trusted 
a variety of professions and occupations 
to tell the truth. The figure (top) shows 
the findings for doctors over time. An 
additional question asked from 1999 to 
2003 explicitly prompted respondents 
over negative publicity on doctors and 
asked whether in the light of this doctors 
did a good job. In 2000 specific reference 
was made to Bristol in the preamble and 
from 2001 onwards reference was also 
made explicitly to Alder Hey (figure 
(bottom)).
Neither set of findings seems to support 
the view that such events shook the 
foundations of public trust and professional 
all conferences and advocacy groups were 
dismantled there might be enough money to 
free Africa of this scourge and liberate much 
productive land. But then there wouldn’t 
be much in it for the drug firms, conference 
centres, caterers, and all those agencies that 
keep academics in business.
Anne savage retired, london NW3 5ra 
savage.anne@btinternet.com
Competing interests: None declared.
1	 	 Richards	T.	The	hitch	hiker’s	guide	to	population	growth	
and	climate	change.	BMJ	2007;335:374.	(25	August.)
UNholy trINIty
stance is worst type of spin
I am not alone in my surprise at seeing 
Delamothe join Dearlove on the moral low 
ground to support his position on the public 
and professional impacts of Bristol, Alder 
Hey, and Shipman.1 Above the shuffling 
of closing medical ranks I can catch the 
words of Hampton’s 1983 editorial on the 
end of clinical freedom, “at best a cloak for 
ignorance, at worst an excuse for quackery.”2
Dearlove demands evidence, as if an 
opiate. Lack of evidence of effect is not 
the same as evidence of lack of effect. The 
Department of Health’s MORI polls, whose 
responses are likely to be driven largely by 
recent direct medical contact, show that 
14-17% of patients have reservations or 
negative opinions about the competence 
of doctors.3-5 In the British social attitudes 
surveys 16% of respondents expressed 
dissatisfaction with general practice and 
more with the NHS generally (www.
data-archive.ac.uk/findingData/bsaTitles.
asp). After Alder Hey, Cancer UK reported 
a sharp fall in donations of tissue to the 
national tumour bank for children’s cancer, 
and 3000 families joined in a legal action 
against the NHS.
To suggest that the political and 
professional responses to the unholy 
trinity were a conspiracy between the 
government and the media is as bizarre 
as failing to recognise that the actions of 
individual doctors and hospitals were not 
isolated events but the alarm symptoms of 
deeper problems. To caricature all this as 
an anti-medical machination of the Blair 
government seems to me the worst kind of 
medical spin.
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confidence. Furthermore, respondents with 
experience of the NHS were more likely to 
state that they thought doctors did their job 
very well.
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sticking to standards,  
not together
If the profession continues to turn a blind 
eye to underperformimg doctors we should 
not be surprised if the government takes 
action.1
We have used locum doctors as part of 
the salvage process for a high health need, 
inner city practice over the past six months. 
Some of them missed potential red flags; 
had poor record keeping, prescribing, and 
referral practices; and proposed out of date 
management of chronic conditions. Some 
from elsewhere in Europe do not know 
how the NHS works, or how to work in 
the NHS. Perhaps not surprisingly—since 
locums are generally unsupervised and 
unsupported—most do not seem to reflect 
systematically on their clinical practice.
So far, in this one practice over the past 
few months, we have referred one doctor 
to the National Clinical Assessment Service 
and another for formal investigation. Dozens 
of others have been referred to their host 
primary care trusts.
We are unusual in having an assertive 
quality process, routinely reviewing the 
day to day work of all our clinicians. And it 
takes up time and resources which we would 
rather spend on our patients.
Perhaps this explains why no one else 
has picked up these issues and these 
doctors. We think that there is widespread 
collusion between employers (often general 
practitioners, sometimes primary care trusts) 
who want holidays and other staff gaps 
filled; locum agencies that are apparently 
oblivious; and other doctors who seem to 
be in denial about poor performance even 
when they notice it.
 Jones calls for professional unity.2 Surely 
this means sticking to standards rather than 
together?
Caroline Mawer general practitioner, Douglas russell 
medical director, Tower Hamlets primary Care Trust, Mile 
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